Articles of Association for Coloplast A/S as adopted at the Annual General Meeting of Coloplast A/S held today, 1 December 2022 are enclosed.
Making life easier for people
with intimate health care needs
Closeness... to better understand
Passion... to make a difference
Respect and responsibility... to guide us
Setting the global standard
for listening and responding
For further information, please contact
Investors and analysts
Executive Vice President, CFO
Tel. +45 4911 1111
Director, Investor Relations
Tel. +45 4911 1800 / +45 4911 2458
Kristine Husted Munk
Sr. Manager, Investor Relations
Tel. +45 4911 1800 / +45 4911 3266
Press and media
Sr. Media Relations Manager
Tel. +45 4911 2623
Company reg. (CVR)
This announcement is available in a Danish and an English-language version. In the event of discrepancies, the English version shall prevail.
Coloplast develops products and services that make life easier for people with very personal and private medical conditions. Working closely with the people who use our products, we create solutions that are sensitive to their special needs. We call this intimate health care. Our business includes Ostomy Care, Continence Care, Wound and Skin Care, Interventional Urology and Voice & Respiratory Care. We operate globally and employ more than 14,500 employees.
The Coloplast logo is a registered trademark of Coloplast A/S. © 2022-12.
All rights reserved Coloplast A/S, 3050 Humlebaek, Denmark.
Coloplast A/S Investor Relations Comp. reg. (CVR).
Holtedam 1 Tel. +45 4911 1800 69749917
DK-3050 Humlebaek Fax +45 4911 1555